Treatment of Alzheimer's disease - Searching for a brearkthrough, settling for less

被引：40

作者：

Drachman, DA ^{[1
]}

Leber, P ^{[1
]}

机构：

[1] US FDA,ROCKVILLE,MD 20857

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1997年 / 336卷 / 17期

关键词：

DEMENTIA;

D O I：

10.1056/NEJM199704243361710

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1245 / 1247

页数：3

共 11 条

[1]

[Anonymous], 1996, Ann Neurol, V39, P29

[2]

[Anonymous], 1996, Ann Neurol, V39, P37

[3]

BERG L, 1988, PSYCHOPHARMACOL BULL, V24, P637

[4] THE PROGNOSIS IN ALZHEIMERS-DISEASE - HOW FAR RATHER THAN HOW FAST BEST PREDICTS THE COURSE [J].

DRACHMAN, DA ;

ODONNELL, BF ;

LEW, RA ;

SWEARER, JM .

ARCHIVES OF NEUROLOGY, 1990, 47 (08) :851-856

[5] THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .11. CLINICAL MILESTONES IN PATIENTS WITH ALZHEIMERS-DISEASE FOLLOWED OVER 3 YEARS [J].

GALASKO, D ;

EDLAND, SD ;

MORRIS, JC ;

CLARK, C ;

MOHS, R ;

KOSS, E .

NEUROLOGY, 1995, 45 (08) :1451-1455

[6] Pharmacology of selegiline [J].

Gerlach, M ;

Youdim, MBH ;

Riederer, P .

NEUROLOGY, 1996, 47 (06) :S137-S145

[7] Observations and suggestions on antidementia drug development [J].

Leber, P .

ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1996, 10 :31-35

[8]

O'Donnell B F, 1992, J Geriatr Psychiatry Neurol, V5, P45

[9]

*PARK STUD GROUP, 1993, NEW ENGL J MED, V328, P176

[10] A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease [J].

Sano, M ;

Ernesto, C ;

Thomas, RG ;

Klauber, MR ;

Schafer, K ;

Grundman, M ;

Woodbury, P ;

Growdon, J ;

Cotman, DW ;

Pfeiffer, E ;

Schneider, LS ;

Thal, LJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 336 (17) :1216-1222

← 1 2 →